Preclinical

Virginia Tech

Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

United States

Post An Enquiry

Virtual Booth

CAMBODIA PHAR-MED 2020

Participation Not Confirmed

Update your events

Virginia Tech Drug Researcher Develops ‘Fat Burning’ Molecule That has Implications for Treatment of Obesity

Lead Product(s): BAM 15

Therapeutic Area: Nutrition and Weight Loss Product Name: Undisclosed

Highest Development Status: Preclinical Product Type: Small molecule

Partner/Sponsor/Collaborator: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable June 05, 2020

Details:

Researcher at the Virginia Tech drug have recently identified a small mitochondrial uncoupler, named BAM15, that decreases the body fat mass of mice without affecting food intake and muscle mass or increasing body temperature.

National Institute on Aging

Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

Post An Enquiry

Virtual Booth

CAMBODIA PHAR-MED 2020

Participation Not Confirmed

Update your events

Repurposed Drug Helps Obese Mice Lose Weight, Improve Metabolic Function

Lead Product(s): Disulfiram

Therapeutic Area: Nutrition and Weight Loss Product Name: Undisclosed

Highest Development Status: Preclinical Product Type: Small molecule

Partner/Sponsor/Collaborator: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable May 14, 2020

Details:

Treatment with disulfiram, normally prescribed to treat alcohol use disorder, shows health benefits in animal study.

Can-Fite BioPharma

Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

ISRAEL Israel

Post An Enquiry

Virtual Booth

CAMBODIA PHAR-MED 2020

Participation Not Confirmed

Update your events

New Pre-clinical Studies Demonstrate Inhibition of Fat Cell Expansion

Lead Product(s): Cannabidiol

Therapeutic Area: Nutrition and Weight Loss Product Name: Undisclosed

Highest Development Status: Preclinical Product Type: Small molecule

Partner/Sponsor/Collaborator: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable March 11, 2020

Details:

New pre-clinical data demonstrating that cannabis derived CBD enriched fractions, supplied by Univo Pharmaceuticals, inhibit the expansion of human fat cells (pre-adipocytes) by 60%.

Find

Find Clinical Drug Development Pipelines & Deals | PipelineProspector

Product Type

Companies

Virginia Tech

Virginia Tech Drug Researcher Develops ‘Fat Burning’ Molecule That has Implications for Treatment of Obesity

National Institute on Aging

Repurposed Drug Helps Obese Mice Lose Weight, Improve Metabolic Function

Can-Fite BioPharma

New Pre-clinical Studies Demonstrate Inhibition of Fat Cell Expansion